Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US Real-World Evidence On COVID-19 Vaccine Safety Is Inadequate, Former HHS Official Says

Oct 29 2021

• By Brenda Sandburg

COVID data — US government is criticized for inadequate use of real-world data in COVID-19 vaccine safety surveillance • Source: Alamy

Related Content

CDC Data More Positive on Myocarditis Benefit-Risk Than FDA’s Assessment of Pfizer’s Vaccine

Sep 01 2021

COVID-19 Vaccine Updates: VITT Has High Mortality, Myocarditis Is Benign Short-Term

Aug 11 2021

With J&J’s COVID Vaccine Pause Now Lifted, The Question Is How Well The System Worked

Apr 24 2021

US FDA’s Confidentiality Policies Seen As Big EUA Shortcoming

Oct 07 2021

Real-World Evidence On COVID-19: US FDA Approaching With 'Sense Of Urgency'

Apr 22 2020

Pfizer Vaccine’s Benefit-Risk Assessment In Older Male Adolescents A Close Call Due To Myocarditis

Aug 25 2021

Related Companies

Pfizer Inc.

BioNTech SE

Moderna, Inc.

Johnson & Johnson

Additional Topics

United States Coronavirus COVID-19 Real-World Evidence Vaccines Policy BioPharmaceutical

More from Real-World Evidence

More from Clinical Trials

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window